Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Centro de Referência da Saúde da Mulher - Hospital da Mulher São Paulo
Homepage:
hospitaldamulhersp.org.br
Alternate names:
Hospital da Mulher,
Hospital da Mulher São Paulo
ROR:
024stfn38
OpenAlex ID:
I4405254708
Breast cancer treatment: A phased approach to implementation
2020
·
Miriam Mutebi
, Benjamin O. Anderson
, et al.
·
Cancer
·
195
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE
2020
·
Stephen R. D. Johnston
, Roberto Hegg
, et al.
·
Journal of Clinical Oncology
·
123
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
2024
·
Christian Marth
, Richard G. Moore
, et al.
·
Journal of Clinical Oncology
·
79
Incontinência urinária no idoso
2003
·
Rodolfo Borges dos Reis
, Adauto José Cologna
, et al.
·
Acta Cirúrgica Brasileira
·
54
PDF
V-Y flap for perineal reconstruction following modified approach to vulvectomy in vulvar cancer
1999
·
F Carramaschi
, M.L.C Ramos
, et al.
·
International Journal of Gynecology & Obstetrics
·
43
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer
2020
·
Erika Hamilton
, Javier Cortes
, et al.
·
Clinical Breast Cancer
·
42
Long-Acting Reversible Contraception
2017
·
Rogerio Bonassi Machado
, Ilza Maria Urbano Monteiro
, et al.
·
Revista Brasileira Ginecologia e Obstetrícia
·
37
PDF
Health of sexual minorities in north-eastern Brazil: representations, behaviours and obstacles
2016
·
Cintia De Lima Garcia
, Grayce Alencar Albuquerque
, et al.
·
Journal of Human Growth and Development
·
37
PDF
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study
2025
·
Matheus de Oliveira Andrade
, Isabella Gonçalves Gutierres
, et al.
·
The Breast
·
29
PDF
Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials
2024
·
Nicole Felix
, Paula C. Nogueira
, et al.
·
European Journal of Internal Medicine
·
29
A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors
2021
·
Amit M. Oza
, François Dubois
, et al.
·
The Oncologist
·
20
PDF
CADONOT: Comparing axillary dissection or not in breast cancer surgery
2025
·
André Mattar
, Marcelo Antonini
, et al.
·
The Breast
·
19
PDF
PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer
2024
·
André Mattar
, Marcelo Antonini
, et al.
·
Annals of Surgical Oncology
·
15
Punção venosa guiada por ultra-som em unidade de terapia intensiva
2009
·
Uri Adrian Prync Flato
, Gustavo Mascari Petisco
, et al.
·
Revista Brasileira de Terapia Intensiva
·
15
PDF
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
2016
·
Roberto Hegg
, André Mattar
, et al.
·
Clinics
·
13
Peri-intraventricular hemorrhage and oxidative and inflammatory stress markers in very-low birth weight newborns
2015
·
Jamil P.S. Caldas
, Carolina A. Braghini
, et al.
·
Jornal de Pediatria
·
13
Estudo da Adesão à Quimioprofilaxia Anti-retroviral para a Infecção por HIV em Mulheres Sexualmente Vitimadas
1999
·
Jefferson Drezett
, Iara Baldacini
, et al.
·
Revista Brasileira Ginecologia e Obstetrícia
·
13
PDF
Twenty years of breast cancer epidemiology and treatment patterns in São Paulo, Brazil—observed versus expected treatment utilization in a retrospective cohort
2025
·
Haydee Verduzco-Aguirre
, Fernanda Mallucelli Favorito
, et al.
·
The Lancet Regional Health - Americas
·
10
PDF
#88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 study
2024
·
Christian Marth
, Richard G. Moore
, et al.
·
International Journal of Gynecological Cancer
·
10
Phase III study of lapatinib (L) plus trastuzumab (T) and aromatase inhibitor (AI) vs T+AI vs L+AI in postmenopausal women (PMW) with HER2+, HR+ metastatic breast cancer (MBC): ALTERNATIVE.
2017
·
William John Gradishar
, Roberto Hegg
, et al.
·
Journal of Clinical Oncology
·
10
Oncological outcomes of breast-conserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohort
2025
·
Francisco Pimentel Cavalcante
, Felipe Pereira Zerwes
, et al.
·
Scientific Reports
·
9
Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study
2025
·
André Mattar
, Marcelo Antonini
, et al.
·
JCO Global Oncology
·
9
PDF
Everolimus (EVE) plus endocrine therapy in patients with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (BC): First- and second-line data from the BOLERO-4 study.
2017
·
Fatima Cardoso
, Cristian Villanueva
, et al.
·
Journal of Clinical Oncology
·
9
Uso da Estimulação Elétrica Nervosa Transcutânea Aplicado ao Ponto de Acupuntura PC6 para a Redução dos Sintomas de Náusea e Vômitos Associados à Quimioterapia Antineoplásica
2012
·
Tania Tonezzer
, Jeani Tagliaferro
, et al.
·
Revista Brasileira de Cancerologia
·
8
PDF
39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembrolizumab (LEN/PEMBRO) vs chemotherapy (chemo) as first-line (1L) therapy for advanced or recurrent endometrial cancer
2024
·
S. Pignata
, C. Marth
, et al.
·
ESMO Open
·
7
PDF
Show more works
View as search
Works count:
115
Citation count:
1,639
Year
Topic
Type
